Macquarie Group
PIII icon

Macquarie Group’s P3 Health Partners PIII Stock Holding History

Macquarie Group’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42
Closed -$935 – 1851
2024
Q2 		$935 Buy
+42
New +$1.25K ﹤0.01% 1845

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group's PIII Position: Q3 2024 in Review

Macquarie Group sold out of P3 Health Partners (PIII) in Q3 2024, closing a stake of 42 shares — an estimated $935 sold.

Macquarie Group first reported a position in PIII in Q2 2024 and held it in 1 quarter. The position peaked at $935 in Q2 2024. 46 funds tracked by Wall St. Rank hold PIII as of Q3 2024.

  • Macquarie Group reported no remaining P3 Health Partners position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 42 P3 Health Partners shares in Q3 2024, an estimated $935.
  • Macquarie Group first reported a position in P3 Health Partners in Q2 2024 and held it in 1 quarter.
  • Macquarie Group's P3 Health Partners position peaked at $935 in Q2 2024.
  • 46 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.